
EnsoData Makes 2023 Inc. Best Workplaces List, Marking 3rd Consecutive Year
EnsoData Ranks Among Highest-Scoring Businesses on Inc. Magazine’s 2023 List of Best Workplaces, marking third consecutive year on the list.
EnsoData Ranks Among Highest-Scoring Businesses on Inc. Magazine’s 2023 List of Best Workplaces, marking third consecutive year on the list.
EnsoData Applies AI to Address Health Concerns for 1,000,000 Patients Worldwide, a milestone reached in May 2023.
EnsoData has appointed Dr. Nathaniel Watson as New Chief Medical Officer, expanding its clinical sleep expertise.
EnsoData’s new funding, coupled with new partnerships and an executive hire, promise rapid growth and accelerated delivery of its validated AI solution for sleep medicine.
EnsoData receives FDA 510(k) clearance of latest sleep center tools to enhance patient care and experience; expands into pediatrics and adds to home testing capabilities.
Cadwell partners with EnsoData with direct integrations to reduce manual data analysis performed by sleep clinicians using Cadwell devices.
By simplifying the process for analyzing the human body to accurately diagnose health conditions, we were thrilled to announce on June 10th the close of our $9 million Series A financing round.
EnsoData, a healthcare artificial intelligence company and maker of FDA-cleared EnsoSleep, publicly announced Tuesday a partnership with LabRetriever [sleep EMR].